BiotechTube

AZD1981 + Neovletta 21/28 + Placebo AZD1981

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Oral Contraceptives

Conditions

Oral Contraceptives

Trial Timeline

May 1, 2010 → Oct 1, 2010

NCT ID
NCT01110525

About AZD1981 + Neovletta 21/28 + Placebo AZD1981

AZD1981 + Neovletta 21/28 + Placebo AZD1981 is a phase 1 stage product being developed by AstraZeneca for Oral Contraceptives. The current trial status is completed. This product is registered under clinical trial identifier NCT01110525. Target conditions include Oral Contraceptives.

What happened to similar drugs?

5 of 20 similar drugs in Oral Contraceptives were approved

Approved (5) Terminated (2) Active (14)
✅AmifostineSun PharmaceuticalApproved
✅tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
✅Essential oils + 0.2% chlorhexidine + Sterile waterJohnson & JohnsonApproved
✅Tranexamic Acid plus standard of carePfizerApproved
✅BivigamADMA BiologicsApproved
❌AL001 + Placebo + Open label - AL001AlectorPhase 3
🔄Micafungin + FluconazoleAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01110525Phase 1Completed

Competing Products

20 competing products in Oral Contraceptives

See all competitors
ProductCompanyStageHype Score
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
AG013OragenicsPhase 2
17
LP-10 (Liposomal Tacrolimus)Lipella PharmaceuticalsPhase 2
29
Micafungin + FluconazoleAstellas PharmaPhase 3
40
micafungin + caspofunginAstellas PharmaPhase 3
40
Erlotinib + PlaceboAstellas PharmaPhase 3
40
AmifostineSun PharmaceuticalApproved
35
exenatide + Other antidiabetic therapiesEli LillyPre-clinical
26
Teriparatide 20 mcgEli LillyPhase 3
40
LY3884963 + Methylprednisolone + Optional Sirolimus + Optional PrednisoneEli LillyPhase 1/2
36
Baricitinib 4 milligram Oral TabletEli LillyPhase 2
39
tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
43
Essential oils + 0.2% chlorhexidine + Sterile waterJohnson & JohnsonApproved
43
galantamine hydrobromideJohnson & JohnsonPhase 2
35
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40
Camrelizumab + Camrelizumanb plus TPFJiangsu Hengrui MedicinePhase 2
35
Camrelizumab plus TP + TPJiangsu Hengrui MedicinePhase 3
47
DurvalumabAstraZenecaPhase 1/2
36
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
29